Research Articles
ROC Curve and AUC in Biomarker Research: A Complete Guide to Diagnostic Discrimination
This comprehensive guide explores the use of Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) for evaluating biomarker discrimination in biomedical research.
Metabolic Targeting in Cancer Immunotherapy: Strategies to Disrupt the Immunosuppressive Tumor Microenvironment
This article provides a comprehensive overview for researchers and drug development professionals on the pivotal role of tumor metabolism in driving immunosuppression.
Lactate's Dual Role: How Metabolic Reprogramming Dictates T Cell Fate in Immunity and Therapy
This article provides a comprehensive analysis of lactate's multifaceted impact on T cell function through metabolic reprogramming, tailored for researchers and drug developers.
Breaking Resistance: How Metabolic Reprogramming in the Tumor Microenvironment Undermines Immunotherapy
This review synthesizes current research on the dynamic metabolic crosstalk within the tumor microenvironment (TME) that drives resistance to immune checkpoint blockade (ICB) and other immunotherapies.
Unleashing the Natural Killers: A Comprehensive Guide to NK Cell Antitumor Mechanisms and Therapeutic Applications
This article provides a detailed analysis of the multifaceted mechanisms underlying Natural Killer (NK) cell-mediated antitumor immunity, tailored for researchers and drug development professionals.
Navigating the Immune Storm: A Comprehensive Guide to Managing irAEs from Immune Checkpoint Inhibitors in Cancer Therapy
This article provides a systematic overview for researchers, scientists, and drug development professionals on the management of immune-related adverse events (irAEs) stemming from Immune Checkpoint Inhibitors (ICIs).
Decoding Macrophage Polarization: IL-4, IFN-γ Signaling and M1/M2 Dynamics in the Tumor Microenvironment
This review provides a comprehensive analysis for researchers, scientists, and drug development professionals on the molecular mechanisms driving macrophage M1 and M2 polarization, with a focus on the opposing signals...
Beyond PD-L1: How Machine Learning Decodes Immunotherapy Resistance Mechanisms for Precision Oncology
Immunotherapy has transformed cancer treatment, yet a majority of patients exhibit primary or acquired resistance, limiting its efficacy.
Decoding Tumor Biomarkers: A Comparative Analysis of MSI, TMB, and PD-L1 Predictive Accuracy in Cancer Immunotherapy
This article provides a comprehensive, up-to-date comparison of three pivotal biomarkers in immuno-oncology: Microsatellite Instability (MSI), Tumor Mutational Burden (TMB), and PD-L1 expression.
M1 vs M2 TAM Ratio: A Critical Prognostic Biomarker in Lymphoma Progression and Treatment Response
This article provides a comprehensive analysis of the prognostic value of tumor-associated macrophage (TAM) polarization, specifically the M1-like to M2-like ratio, in lymphoma.